← Back to patent-cliff list
乙醇达芦那韦/利托那韦
Tier C — Watch / tradeDarunavir Ethanolate/Ritonavir
Laboratorios Richmond
Originator
2015
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：HIV-1 protease
Brand：Virontar N、Virontar
Indications (approved)：HIV感染
Regional status
US
-
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Darunavir Ethanolate/Ritonavir?
Approved indications include: HIV感染.
When does the Darunavir Ethanolate/Ritonavir patent expire?
No public expiry year is available for Darunavir Ethanolate/Ritonavir yet; this page updates once verified.
How do I get a quote for Darunavir Ethanolate/Ritonavir intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24